Publications by authors named "Peter Hammarsten"

Claim this Profile
I
Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
Peter Hammarsten, Andreas Josefsson, Elin Thysell, Marie Lundholm, Christina Hägglöf

Mod Pathol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
Hanibal Adamo, Peter Hammarsten, Christina Hägglöf, Tove Dahl Scherdin, Lars Egevad

Prostate· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.
Peter Hammarsten, Tove Dahl Scherdin, Christina Hägglöf, Pernilla Andersson, Pernilla Wikström

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.
Maria Nilsson, Christina Hägglöf, Peter Hammarsten, Elin Thysell, Pär Stattin

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.
Peter Hammarsten, Johanna Winther, Stina H Rudolfsson, Jenny Häggström, Amar Karalija

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological and morphometric characterization of direct transdifferentiation of support cells into hair cells in ototoxin-exposed neonatal utricular explants.
Mimmi Werner, Thomas R Van De Water, Peter Hammarsten, Göran Arnoldsson, Diana Berggren

Hear Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.
Christina Hägglöf, Peter Hammarsten, Kerstin Strömvall, Lars Egevad, Andreas Josefsson

PLoS One· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.
Jenny Häggström, Mariateresa Cipriano, Linus Plym Forshell, Emma Persson, Peter Hammarsten

Prostate· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin

Eur J Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.
Francesca Bruzzese, Christina Hägglöf, Alessandra Leone, Elin Sjöberg, Maria Serena Roca, Peter Hammarsten

Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.
Mariateresa Cipriano, Jenny Häggström, Peter Hammarsten, Christopher J Fowler

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten

Biochim Biophys Acta· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
Andreas Josefsson, Hani Adamo, Peter Hammarsten, Torvald Granfors, Pär Stattin

Am J Pathol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
Marcus Thomasson, Baofeng Wang, Peter Hammarsten, Anna Dahlman, Jenny Liao Persson

Int J Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer.
Sofia Halin, Peter Hammarsten, Hani Adamo, Pernilla Wikström, Anders Bergh

Expert Opin Med Diagn· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
Christopher J Fowler, Peter Hammarsten, Anders Bergh

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.
Anna Johansson, Stina Rudolfsson, Peter Hammarsten, Sofia Halin, Kristian Pietras

Am J Pathol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.
Lina Thors, Anders Bergh, Emma Persson, Peter Hammarsten, Pär Stattin

PLoS One· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
Christina Hägglöf, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Janna Paulsson

PLoS One· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Peter Hammarsten, Amar Karalija, Andreas Josefsson, Stina Häggström Rudolfsson, Pernilla Wikström

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.
Sui Chu Chung, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Torvald Granfors

Eur J Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats.
Peter Hammarsten, Stina Häggström Rudolfsson, Roger Henriksson, Pernilla Wikström, Anders Bergh

Prostate· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.
Sofia Halin, Peter Hammarsten, Pernilla Wikström, Anders Bergh

Prostate· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.
Peter Hammarsten, Sofia Halin, Pernilla Wikstöm, Roger Henriksson, Stina Häggström Rudolfsson

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis